Ikarian Capital »

Jasper Therapeuritc shares owned by Ikarian Capital

Quarter-by-quarter ownership of Jasper Therapeuritc (JSPR) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Jasper Therapeuritc

Tip: Access up to 7 years of quarterly data

All positions including Jasper Therapeuritc held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jasper Therapeuritc by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.2M 55k 21.38
2024-09-30 $1.0M 55k 18.81
2024-06-30 $2.4M 105k 22.70
2024-03-31 $3.1M 105k 29.36

More positions owned by Ikarian Capital

Spdr Ser Tr S&p Biotech Put Option (XBI)
Tyson Foods Cl A Put Option (TSN)
Tarsus Pharmaceuticals (TARS)
Crinetics Pharmaceuticals In (CRNX)
Bridgebio Pharma Call Option (BBIO)
Scholar Rock Hldg Corp Call Option (SRRK)
Amgen Call Option (AMGN)
Insmed Com Par $.01 Call Option (INSM)
Blueprint Medicines (BPMC)
Avidity Biosciences Ord Put Option (RNA)
Sarepta Therapeutics Call Option (SRPT)
Forte Biosciences Com New (FBRX)
Pilgrim's Pride Corporation Put Option (PPC)
Neumora Therapeutics Put Option (NMRA)
Miragen Therapeutics Call Option (VRDN)

View all positions for Ikarian Capital

Top funds holding Jasper Therapeuritc

Soleus Capital Management
Velan Capital Investment Management
Carlyle
Qiming U.S. Ventures Management
BlackRock
Braidwell
Vanguard Group
Integral Health Asset Management
Morgan Stanley
Samsara BioCapital
Polar Capital Holdings
Franklin Resources
Rock Springs Capital Management
Kingdon Capital Management
Citadel Advisors

View all funds holding Jasper Therapeuritc